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A new in vitro fermentation model with immobilised infant faecal microbiota simulating the proximal colon of a formula-fed baby was developed
and used to test the effects of known prebiotic fructans. Intestinal fermentation, based on a previously developed colonic fermentation model, using
a new feeding medium simulating a formula-fed infant ileal chyme, was carried out for seventy-one consecutive days divided into four stabilisation
periods intercalated with four prebiotic treatment periods. At the end of the first stabilisation period, total bacterial concentration in colonised beads
and in faecal sample was similar, metabolite concentrations returned to stabilisation values after each treatment period. As expected, the four pre-
biotic treatments significantly increased the bifidobacterial populations, whereas they decreased bacteroides and clostridia. No difference was
observed in the prebiotic effect of these substrates selected. The treatments significantly increased total production of SCFA and decreased ammo-
nia compared to stabilisation periods. Long-term stability of the system together with the reproducibility of the known prebiotic effects highlights
the potential of the present model to quantify and compare the effects of different substrates in a formula-fed infant microbiota within the same
fermentation experiment.
In vitro colon model: Immobilised faecal microbiota: Formula-fed infants: Prebiotics: Fructans
The intestinal microbiota performs important metabolic and
immunological functions and acts as a biological barrier against
pathogens. Its composition has been found to vary with age.
Initially sterile, the gastrointestinal tract of newborn is rapidly
colonised by bacteria from both maternal vaginal and faecal
microbiotas and the surrounding environment through a com-
plex process(1). The microbial ecology of the infant gut is influ-
enced by diet among other environmental and genetic factors. It
is generally believed that breastfed infants have a microbiota
dominated by bifidobacteria and lactobacilli, creating a protec-
tive environment against pathogens(2). Formula-fed infants with
a more complex microbiota are more susceptible to intestinal
disorders(3). Human milk contains high levels of oligosacchar-
ides that stimulate the growth of indigenous bifidobacteria and
lactobacilli and may contribute to the protection of breast-fed
infants against infections and inflammations(4,5). There is
great interest to develop new infant formula sustaining gut
microbiota akin to breast-fed infants.
Dietary modulation of the gut microbiota by probiotics
and prebiotics is an important feature in nutritional sciences.
A prebiotic is a selective fermented ingredient that promotes
specific changes, both in the composition and/or activity of
the gastrointestinal microbiota that confers benefits upon
host well being and health(6). Inulin and oligofructose have
been shown to inhibit growth of pathogens and to display a
bifidogenic effect associated with a decrease in Bacteroides
spp. and clostridia counts. These two b(2-1) fructans differ
according to their degree of polymerisation (DP). Inulin pro-
duced by extraction from chicory roots has a DP between 3
and 60, while oligofructose presenting a DP between 2 and
10 is obtained from inulin hydrolysis(7). The bifidogenic
nature of fructans is partly explained by the higher competi-
tiveness that most bifidobacterial strains exhibit over other
intestinal bacteria(8). The DP was a determining factor in Bifi-
dobacterium metabolism of fructans(9). Generally, as chain
length increased, the consumption of fructans by bifidobac-
teria decreased. Distinct preferences for chain length were
observed according to bifidobacteria strains(10 – 12). Specific
enzymatic systems allowing hydrolysis of oligofructose only,
inulin only or both could explain these differences(10).
Prebiotics’ effects have been extensively studied in ani-
mals(12 – 14) and healthy adults(11,15,16), but in vitro models
may offer an interesting alternative since they are generally
inexpensive to operate, easy to set up with no ethical
needs(17) and provide a dynamic overview of gut microbial
activity and composition over several weeks. Effects of
soluble and insoluble fibres have already been studied on the
adult gut microbiota using different anaerobic fermentor
systems(18,19), but very few studies have been focused on infant
gut microbiota(20). Indeed, there is no in vitro fermentation
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model specifically set for formula-fed infant gut microbiota
with low bifidobacteria concentrations, although such model
would be advantageous for testing substrates for enhancing
bifidobacteria concentration.
In the present study, a new in vitro fermentation model with
immobilised infant faecal microbiota simulating the proximal
colon of a formula-fed baby was established and used to inves-
tigate its application to prebiotic fructans. The present model
based on recent models developed for simulating weaning
infant(20,21) and adult(22)was associated with a newly devel-
oped feeding medium simulating the ileal chyme reaching
the proximal colon of infant below 4 month-old fed with a
standard infant milk formula. Composition and activity of a
formula-fed infant microbiota subjected to four prebiotic sub-
strates were daily monitored during a 71-d continuous
fermentation.
Methods
Faeces collection and preparation of the bioreactor inoculum
The faecal sample used for immobilisation was provided by a
healthy young (4 month old) male infant fed from birth with a
non-prebiotic-supplemented formula (Milupa Aptamil HA1,
Milupa GmbH, Friedrichsdorf, Germany) who had never
received antibiotics. A fresh faecal sample (11 g) was scraped
from the diaper, transferred to a tube containing 5 ml of sterile,
pre-reduced peptone water (0·1 %, pH 7), and placed in an
anaerobic jar with a CO2 generation system (Oxoid Anaero-
Gen TM, Oxoid AG, Basel, Switzerland) by the mother just
after defecation. The faecal sample was kept in anaerobiosis,
on ice and delivered to the laboratory within 1 h. Immediately
upon reception, the faecal suspension was weighed and the
volume adjusted with reduced peptone water (0·1 %, pH 7)
under anaerobic conditions (anaerobic chamber; Coy Labora-
tories, Ann Arbor, MI, USA) to obtain a final faecal concen-
tration of 20 % (w/v). This inoculum was then homogenised
and centrifuged (700 g for 1 min; Biofuge Primo Heraeus,
DJB Labcare Ltd, Newport Pagnell, UK) to remove large
particles.
Immobilisation technique
After centrifugation, the inoculum was immobilised in
1–2 mm diameter gel beads composed of 2·5 % gellan gum,
0·25 % xanthan gum and 0·2 % sodium citrate (v/w; Sigma-
Aldrich Chemie GmbH, Buchs, Switzerland). This technique
is based on a dispersion process in a two-phase system(18).
Briefly, the polymer solution was autoclaved, cooled to 438C
and inoculated aseptically with the faecal inoculum (2 %).
After inoculation, the polymer solution was stirred into freshly
autoclaved (15 min at 1218C) commercial rapeseed oil at 438C
to obtain a suspension of aqueous droplets in oil. Gel beads
were formed by cooling the suspension. After separation and
washing, beads were hardened by soaking for 30 min in
CaCl2 (0·1 M). Beads with diameters in the 1·0–2·0 mm
range were selected for fermentation by wet sieving. The
entire process was completed under anaerobiosis in aseptic
conditions within 1 h. Gel beads (60 ml) were then transferred
to the bioreactor (Sixfors, Ismatec, Glattbrugg, Switzerland)
with 140 ml fresh nutritive medium. The entire procedure
from faeces collection to the reactor inoculation was carried
out under anaerobic conditions and completed within 3 h
after defecation. A bead aliquot (0·5 g) was analysed just
after immobilisation for viable counts.
Fermentation media
Two nutritive media were designed to simulate ileal chymes
of infants fed with formula supplemented or without prebiotic
substrates. Two typical infant formulas used in Europe, with a
carbohydrate:N-compounds ratio of 83:17, SANOR 1 ORAF
SYNG A (lactose 72 g/l, casein 6 g/l and whey proteins 9 g/l)
and SANOR 1 ORAF SYNG B (lactose 67·7 g/l, prebiotic
4·3 g/l, casein 6 g/l and whey proteins 9 g/l; Orafti, personal
communication) have been used to calculate the non-prebiotic
and prebiotic nutritive media compositions using a similar
approach as described in Cinquin et al. (21) with some
modifications. Digestibility indices for lactose (98 %; Kien
et al. (23)), casein (98 %; Drescher et al. (24)), whey proteins
(80 %; Lindberg et al. (25)) and prebiotics (0 %) (Orafti, per-
sonal communication) were applied to each compound in
order to obtain new carbohydrate:N-compounds ratios in the
non-prebiotic (43:57) and prebiotic (74:26) nutritive media
simulating undigested substrates present in infant ileal
chymes reaching the proximal colon. The total substrate
concentration (carbohydrates and N-compounds) in the non-
prebiotic medium was set at 15 g/l leading to new concen-
trations of lactose (6·4 g/l), casein (0·5 g/l) and whey proteins
(8·1 g/l). The concentration of N-compounds (casein plus
whey proteins) obtained after calculation for the non-prebiotic
medium (8·6 g/l) was kept constant in the prebiotic-sup-
plemented medium. This led to an increase in the total substrate
concentration of 32·6 g/l (lactose 6·1 g/l, prebiotic 17·9 g/l,
casein 0·5 g/l and whey proteins 8·1 g/l) in the prebiotic-
containing medium due to the high proportion of prebiotic
theoretically available in the infant ileal chyme. Prebiotic sub-
strates in the present study were provided by Beneo Orafti
(Tienen, Belgium). Oligofructose (Oraftiw P95, P95) is com-
posed of 95 % oligosaccharides with DP 2–9; oligofructose-
enriched inulin (Oraftiw Synergy 1, Syn) is composed of 30 %
oligosaccharides with DP 2–9 and 70 % inulin with DP $ 10;
high solubility inulin (HSI, Oraftiw HSI) is composed of 60 %
oligosaccharides with DP 2–9 and 28 % inulin with DP $ 10.
Unless otherwise stated, all chemicals were obtained from
Sigma-Aldrich Chemie GmbH.
The two nutritive media were supplemented with (g/l of dis-
tilled water): ox bile salts (0·05), porcine gastric mucin type
(4·0), yeast extract (2·5), hemin (0·01), Tween 80 (1), peptone
(0·5), tryptone (0·5), salts (NaCl, 4·5; KCl, 4·5; MgSO4
7H2O, 1·25; CaCl2, 2H2O, 0·15; K2HPO4, 0·5; NaHCO3, 1·5;
FeSO4 7H2O, 0·005) and cysteine (0·8). A sterile-filtered
vitamin solution was added (0·5 ml/l) separately to the
autoclaved (15 min, 1218C) medium (Michel et al. (26)).
Although less concentrated than in the prebiotic nutritive
medium, the amount of substrates in the non-prebiotic
medium (15 g/l) was assumed to give sufficient fermentable
substrates to sustain physiological bacterial growth (total
bacteria in the range from 9 to 10 log colony-forming units
(CFU)/ml) and metabolic activity (at least 70 mM total
SCFA in fermented medium) simulating an infant colonic
microbial ecosystem (Mountzouris et al. (3)). This reduced
G. Le Blay et al.404
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level of substrates was also chosen to avoid an excess of fer-
mentable substrates in the prebiotic medium leading to non-
physiological values. Prebiotic substrates were provided by
Orafti. Unless otherwise stated, all chemicals were obtained
from Sigma-Aldrich Chemie GmbH.
Fermentation procedure
For bead colonisation, batch fermentations were first carried out
in a bioreactor with a fermentation volume of 200 ml (Sixfors,
Ismatec, Glattbrugg, Switzerland) containing 30 % of freshly
inoculated beads (v/v). During colonisation (days 1 and 2), the
fermented medium was aseptically replaced by fresh medium
every 12 h. The reactor was maintained at 378C, under continu-
ous stirring (120 rpm) and anaerobic conditions by a continuous
flow of pure CO2. The pH was adjusted to 6 by the addition of
4 M NaOH. The continuous fermentation was carried out in
the same reactor connected to a stirred feedstock vessel contain-
ing sterile culture medium continuously flushed with CO2 and
maintained at 48C and to an effluent receiving vessel. Continu-
ous medium feeding was carried out using peristaltic pumps
(Reglo analog, Ismatec, Glattbrugg, Switzerland) delivering a
feed flow rate of 40 ml/h for a mean retention time in the reactor
of 5 h. This time was used to simulate the residence time in
infant proximal colon, estimated for a total transit time of 23 h
according to Sievers et al. (27) who described a total transit
time ranging from 5·4 to 36·5 h in formula-fed infants aged
113 d. The fermentation was divided into eight test periods
(Fig. 1). Four stabilisation periods with the non-prebiotic
medium (stab 1–4: 12, 10, 8 and 8 d, respectively) were interca-
lated with four prebiotic treatment periods for the three
substrates to be tested, P95 (8 d), HSI (8 d) and Syn (8 d) includ-
ing a repetition of the P95 treatment (7 d) at the end of the exper-
iment. During the fermentation experiment, beads were
collected on the last day of each treatment period and effluent
samples (13 ml) were collected daily. Plating was done immedi-
ately after collecting the samples, whereas fixed effluent
samples and effluent supernatants were stored at 2808C for a
maximum of 5 months for fluorescence in situ hybridisation
(FISH) and metabolite analyses according to Cinquin et al. (28).
Bacterial enumeration by plate counts
Plate counts on non-selective (Wilkins Chalgren) and selective
(Beeren’s) media for total anaerobes and bifidobacterial popu-
lations, respectively, were performed daily on reactor effluents
and on beads at the end of each test period. Major bacterial
populations present in faeces and in beads (just after immobil-
isation and from the last day of stab 1) were enumerated on a
panel of non-selective (Wilkins Chalgren and Nutrient Agar)
and selective (Beeren’s Agar, Lamvab, Reinforced Clostridial
Agar, Bacteroides Mineral Salt Agar, MacConkey Agar, Azide
Blood Agar and Mannitol Salt Agar) media, as described by
Cinquin et al. (21). Samples were decimally diluted in reduced
peptone water (0·1 %, pH 7) under anaerobic conditions
(anaerobic chamber; Coy Laboratories), and drops of 20ml
appropriate dilutions were placed in a Petri dish. After
drying of the drops, the plates were incubated aerobically or
in anaerobic jars at 378C for up to 5 d. Cell counts were per-
formed in duplicate and expressed as log10 CFU per g (wet
weight) of faeces, per ml of fermentation medium or per g
(wet weight) gel beads.
Bacterial enumeration by fluorescent in situ hybridisation
Light microscopy was performed after completion of the con-
tinuous culture on glass slides with faecal inocula and fermen-
tation samples from the last 4 d of each pseudo steady-state
periods (stabilisation and treatment periods), as described by
Schwiertz et al. (29) and Cinquin et al. (28). Different oligonu-
cleotide Cy3-labelled probes (Microsynth GmbH, Balgach,
Switzerland), with hybridisation conditions (lysozyme treat-
ment, buffers and hybridisation temperatures) specific for
each probe as described in Cinquin et al. (28), were used to
detect the main populations: Eub338 for total bacteria(30);
Bif164 for Bifidobacterium spp.(31); Bac303 for Bacter-
oides–Prevotella cluster(32); Lab158 for Lactobacillus and
Enterococcus (33), and Erec482 for Clostridium coccoides–
Eubacterium rectale group(34). For total cell counts, 40,6-dia-
midino-2-phenylindole (Sigma-Aldrich Chemie GmbH) was
added at a final concentration of 1mg/ml Citifluorw (Citifluor
Ltd, London, UK), which was used as mounting medium to
prevent fading of fluorescence. Cells were counted visually
with an Olympus BX 60 epifluorescence microscope (Olym-
pus Schweiz AG, Volketswil, Switzerland) on 10-well slides
(Fisher Scientific SA, Wohlen, Switzerland). Bacterial concen-
trations were calculated from the bacterial density correspond-
ing to fifteen annular regions to minimise the counting error
due to the radial distribution of bacteria in wells as already
described by Cinquin et al. (28). Each assay was carried out
in duplicate. The detection limit of the method was log 6·0 cell
number per ml of fermentation effluents or g of faeces.
Metabolite analyses
HPLC (Hitachi LaChrome, Merck, Dietikon, Switzerland)
analyses for SCFA (acetate, propionate, butyrate and formate),
iso-acids (iso-butyrate and iso-valerate) and lactate were per-
formed after completion of the continuous culture, with
frozen supernatants of the faecal inoculum and fermentation
samples (1·5 ml) from the last 4 d of each pseudo steady-
state treatment period, as described by Cleusix et al. (22).
Ammonia concentration was measured with an ammonia elec-
trode (Metrohm, Herisau, Switzerland). All analyses were
done in duplicate and expressed in mM.
Statistical analyses
A one-way ANOVA was performed using SPSS 13 (SPSS
Inc., Chicago, IL, USA) to test the effects of the different
substrates on bacterial populations and metabolite produc-
tion during the last 4 d of the pseudo steady-state periods.
Fig. 1. Schedule of the experimental colonic fermentation used to test three
prebiotic substrates: P95 (oligofructose, Oraftiw P95); HSI (inulin, Oraftiw
HSI); Syn (oligofructose-enriched inulin Oraftiw Synergy 1) in the intestinal
fermentation model with immobilised infant microbiota (stab: stabilisation
periods with the control fermentation medium).
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When significant differences were found below the probability
level of 0·05, treatment means were compared using the
Tukey–Kramer’s honestly significant difference test.
Results
Immobilisation, bacterial diversity and stability
Bacterial populations measured by plate counts in faeces and
in beads just after immobilisation and at the end of stab 1
are presented in Table 1. Population of bifidobacteria enumer-
ated in faeces used to inoculate the reactor was 6·2 log CFU/g
faeces, 9·9 log CFU/g faeces for clostridia and 9·7 log CFU/g
faeces for gram-positive cocci. Immediately after immobilis-
ation, all bacterial populations tested were detected in beads
at lower concentrations than in faeces. They showed survival
rates between 25 and 157 %, with the exception of Clostridium
spp. and gram-positive cocci showing only 1 and 4 % of cells
surviving bead entrapment. At the end of stab 1, beads were
highly colonised by bacteria. Concentrations close to the
faecal ones with differences ranging from 0·2 to 0·7 log units
were obtained for most populations. Clostridia and bacteroides
presented, however, a lower (by 1·4 log units) and a much
higher (by 3·2 log units) concentration in beads than in the
infant faeces. These results were confirmed on faecal and
effluent sample populations analysed with the FISH technique
(Table 2). Major bacterial groups recovered in faeces were
also present in effluent samples and reached high and stable
values with standard deviations equal or below 0·3 units for
four consecutive days at the end of stab 1.
Effect of prebiotics on bacterial populations enumerated with
plate counts
Concentrations of total anaerobes and bifidobacteria were
monitored in beads (at the end of each stabilisation period)
and effluent samples (daily) by plate counts during the
whole fermentation (Table 2 and Fig. 2). Total anaerobe con-
centrations were high and stable, with general means of 10·1
(SD 0·2) log CFU/g and 9·6 (SD 0·3) log CFU/ml in beads
and effluent samples, respectively. In contrast, bifidobacterial
Table 1. Viable bacterial populations measured with plate counts in
faeces (log colony-forming units (CFU)/g) and in beads (log CFU/g) just
after immobilisation and at the end of the first pseudo-steady state
stabilisation period of the continuous colonic fermentation
Faeces Immo
Survival
rate (%)* Stab 1
Total anaerobes 10·7 7·3 10 10·2
Facultative anaerobes 8·7 6·1 63 8·9
Clostridia 9·9 5·6 1 8·5
Bacteroides 6·6 4·0 63 9·8
Bifidobacteria 6·2 4·0 158 5·5
Coliforms 8·6 5·6 25 ND
Gram-positive cocci 9·7 5·9 4 9·2
Staphylococci 8·2 5·5 50 ND
Reported data are means of duplicate plating of single sample of faeces or beads
(n 1). Immo, immobilisation; stab1, first stabilisation period.
* Calculated by the ratio of cell count in beads after Immo to theoretical cell count in
beads with 100 % cell survival. Theoretical cell count in beads was calculated
considering a fivefold dilution from faeces to faecal cell suspension and 2 %
bead inoculation with faecal cell suspension. T
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concentrations were strongly (P,0·05) increased during the
four prebiotic treatments compared to the preceding stabilis-
ation periods (Table 2). In effluent samples, the bifidobacterial
concentrations obtained during P95 treatments (first and
second) were significantly higher (P,0·05) than those
obtained with HSI, which were not different from Syn.
These findings were confirmed in beads, which showed the
same trends (Table 2). An increase in bifidobacteria counts
in effluent samples over the 71 d of fermentation led to signifi-
cantly lower and higher concentrations in stab 1 and stab 4
(5·6 and 8·0 log CFU/ml, respectively) compared with stab 2
and stab 3 (7·1 and 7·0 log CFU/ml, respectively). This
makes comparison of P95 with the two other prebiotics
(HSI and Syn) treatments difficult.
Effect of prebiotics on bacterial populations enumerated with
fluorescence in situ hybridisation
Bacterial populations were enumerated with FISH microscopy
in effluent samples only (Table 2). The total bacterial popu-
lation was high and stable over the whole fermentation (9·8
(SD 0·2) log cell number/ml). Bifidobacteria were significantly
increased by 1·8 log units during P95 (first treatment) and
1·0–1·1 log units during the other three prebiotic treatments
(HSI, Syn and P95 second treatment) compared to the preced-
ing stabilisation periods. No significant differences were
detected for bifidobacterial concentrations between P95 (first
treatment), HSI and Syn with mean values of 8·0 (SD 0·1),
8·0 (SD 0·1) and 8·1 (SD 0·1) log cell number/ml, respectively.
P95 (second treatment) induced a significantly higher bifido-
bacterial concentration (8·5 (SD 0·2) log cell number/ml)
compared with the three first treatments (P95, HSI and Syn).
As observed with plate counts, bifidobacterial concentrations
measured with FISH gradually increased from stab 1 to
stab 4, but to a lesser extent. It should be noted that bifidobac-
terial concentrations obtained with plate counts were system-
atically higher (plus 0·3–1·1 log units) than data obtained
with FISH analyses during the four prebiotic treatments.
In contrast to bifidobacteria, C. coccoides–E. rectale group
and Bacteroides–Prevotella cluster slightly decreased during
prebiotic treatments compared to the previous stabilisation
periods. These decreases were significant (P,0·05) for
Bacteroides–Prevotella cluster during P95 (first treatment)
and HSI, and for the C. coccoides–E. rectale group during
Syn and P95 (second treatment). No effect was observed on
the lactobacilli–enterococci counts, with a mean of 9·1 (SD
0·2) log cell number/ml over the whole fermentation.
Effect of prebiotic substrates on metabolic activities
SCFA, iso-acids, lactate and ammonia concentrations were
analysed in faeces and in effluent samples during the whole
fermentation trial, and means were calculated for the last 4 d
of each treatment period. The total SCFA concentration
(90·3 mM) measured in the faecal sample was divided into
61 % acetate, 34 % propionate and 5 % butyrate. Similar con-
centrations for total SCFA were tested during the four stabil-
isation periods (ranging from 79 to 88 mM), but with different
SCFA ratios (Table 3). The percentage of butyrate increased
(19·0 (SD 2·4) %) and that of acetate decreased (220·5
(SD 3·1) %) compared to faeces whereas the percentages of
propionate and formate remained constant. Iso-acids and
ammonia concentrations were high in the range from 13 to
15 mM and from 64 to 74 mM, respectively. There were no
significant differences between the four stabilisation periods
for all parameter analysed, showing that the system was
stable and suggesting that different treatments can be
compared within the same fermentation experiment.
P95 and HSI, and Syn to a lesser extent, increased
(P,0·05) the fermentation capacity of the microbiota. The
acetate ratio largely increased, whereas propionate and buty-
rate ratios decreased during prebiotic treatments (Table 3).
These increases in SCFA production were concomitant with
a decrease in ammonia and iso-acid concentrations and an
increase in formate concentrations. The dynamic effect of pre-
biotics on SCFA concentrations is presented in Fig. 3 with a
rapid increase in acetate concentration followed by a transient
increase in lactate concentration, except for P95 (first treat-
ment) where no increase in lactate concentration was
observed.
Discussion
In the present study, we tested the effects of three different
fructans (oligofructose, oligofructose-enriched inulin and
inulin) during the same colonic fermentation performed with
a new fermentation model simulating the proximal colon of
a young formula-fed infant.
Fig. 2. Changes in total anaerobes and bifidobacteria concentrations in effluent fermentation samples during the continuous fermentation. Total anaerobes (W),
bifidobacteria (X). Stab 1–4, stabilisation periods with the non-prebiotic medium; P95, medium supplemented with oligofructose (Oraftiw P95); HSI, medium
supplemented with inulin (Oraftiw HSI); Syn, medium supplemented with oligofructose enriched-inulin (Oraftiw Synergy 1); CFU, colony-forming units.
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The faecal sample obtained from a 4-month-old, 100 % for-
mula-fed baby harboured high clostridia and bacteroides and
low bifidobacteria concentrations with a SCFA profile domi-
nated by acetic and propionic acids with no lactic acid and
a low level of butyric acid, which is commonly met in for-
mula-fed infants(3,35). As already observed in a previous
study (Cinquin et al. (21)), immobilisation allowed the recovery
of the main bacterial populations. All major groups of intesti-
nal bacteria found in faeces were present in beads and effluent
samples and reached stable and similar values as in faeces at
the end of the first stabilisation period.
During the four stabilisation periods, bacterial populations
with highest numbers in reactor effluents were the Bacter-
oides–Prevotella cluster and C. coccoides–E. rectale group,
which belong to the dominant populations of formula-fed
infants, as described by Edwards & Parrett(35) and Harmsen
et al. (36). Lactobacilli and/or enterococci, detected with the
oligonucleotide probe Lab158, were also present in high
numbers. Contrary to infant faeces and literature data
(Edwars & Parett(35)), the butyrate percentages for the
different stabilisation periods simulating a formula-fed baby
were very high (22–27 %). This was likely a result of the
high concentration of C. coccoides–E. rectale group, which
harbours a high proportion of butyrate-producing bacteria(37).
Our data for the selected medium composition and
fermentation conditions (pH 6, mean retention time of 5 h)
fully met initial assumptions for total anaerobes and
bifidobacteria concentrations (in the range from 109 to
1010 CFU/ml and below 109 CFU/ml, respectively) and meta-
bolic activity (at least 70 mM SCFA in the fermentation
medium) in the infant model. The reduced amount of sub-
strates (15 g/l) in the control non-prebiotic medium provided
a sufficient source of fermentable substrates to allow bac-
terial growth and metabolic activity comparable to that of
an infant microbiota. These results on total bacterial and
total metabolite concentrations measured in reactor effluents
during the four stabilisation periods were in accordance with
physiological values of the proximal colon of a 4-month-old
formula-fed infant (total anaerobes of 8·5–10·5 log CFU/g
faeces(29) and total SCFA concentrations of approximately
70–130 mmol/kg faeces according to Mountzouris et al. (3)).
Lactobacilli and/or enterococci, detected with oligonucleotide
probe Lab158, were also present in high numbers. There
were no significant differences among the four different
stabilisation periods concerning bacterial and metabolite
concentrations in effluent samples from the last 4 d of each
period, except a progressive increase in bifidobacterial
concentrations, which can be explained by additional coloni-
sation of beads with bifidobacteria during prebiotic periods.
To improve the accuracy of the comparison and limit this
bifidobacteria counts drift in beads during successive pre-
biotic and stabilisation periods, it may prove useful to first
increase the bifidobacterial concentration in colonised beads
using a chyme-simulating medium supplemented with a
prebiotic substrate, and then change the composition of the
medium to produce low bifidobacteria counts in the effluent
medium during stabilisation periods for comparison with
prebiotic treatments. However, our present data show the
good stability of the colonic model and indicate the validity
of the comparison between successive treatments applied
during the same fermentation experiments.T
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Bacteria enumeration with FISH and plate counts for total
anaerobes and bifidobacteria gave similar results (Table 2).
A significant increase (P,0·05) in the bifidobacterial
population was observed with both methods in reactor efflu-
ents for the three fructans studied to the preceding stabilisation
periods, while the total anaerobes remained high and stable.
Significant differences in bifidobacterial concentrations were,
however, observed between the methods. The differences
between FISH and plate counts may be due to different
species being targeted by the two methods(21,31). Bifidobac-
terium adolescentis population has been stimulated by
inulin supplementation in a recent study(11), but media for
bifidobacteria such as Beeren’s underestimate the number of
B. adolescentis (38). By contrast, bifidobacterial concentrations
were sometimes found higher with plate counts than by
FISH analysis, and selectivity of all media for bifidobacteria
can be questioned(39).
The increase in bifidobacterial counts between prebiotic
treatments and preceding stabilisation periods ranged from
1·0 to 3·2 log units, depending on the method of analysis
and prebiotic treatment. The greatest increase was observed
for the first P95 treatment, independent from the method of
analysis. This is explained likely by the low counts of bifido-
bacteria measured during stab 1 compared with the other
stabilisation periods. There is a stronger bifidogenic effect of
prebiotics for low initial levels of bifidobacteria(40). But this
difference could be also explained by the different DP
distribution of P95 since oligofructose could have a stronger
effect(13)or a more rapid effect on bifidobacteria increase
than HSI(41,42). Indeed, long-chain fructans with DP . 10
are fermented on average half as fast as short-chain fructans
with DP , 10(43). For all other prebiotic treatments (P95,
Syn and HSI), the increase in bifidobacterial counts was
similar when analysed by FISH.
Lactobacilli can also increase with prebiotics, whereas
bacteroides and clostridia may decrease(12,44,45). Data obtained
for reactor effluents analysed with FISH showed a decrease in
Bacteroides–Prevotella cluster and C. coccoides–E. rectale
group with prebiotic treatments (although not statistically
significant for all treatments). There was no significant
increase in the lactobacilli–enterococci populations for any
of the prebiotic substrates tested.
As expected, all four prebiotic treatments significantly
increased SCFA production and decreased ammonia compared
to stabilisation periods. This can be explained by the large
change of carbohydrates:N-compounds ratio between prebiotic
and control treatments with about four times higher carbo-
hydrate concentrations during prebiotic treatments in the feed-
ing medium(12,28,44). DP distribution did not influence the
prebiotic effect of substrates in the present study contrary to
Van de Wiele et al. (18)who suggested a more pronounced
in vitro prebiotic effect of fructans of longer DP. Butyrate
concentrations significantly increased during prebiotic treat-
ments, except for Syn. However, in the present study, the
increase in butyrate was not specific, but due to a general
increase in the fermentation activity. No increase in the butyrate
ratio was observed during prebiotic treatments, probably due to
an already high butyrate concentration (and ratio) present during
stabilisation periods or the transformation of lactate into pro-
pionate instead of butyrate(12,46). Lactate, as a transient metab-
olite, was primarily produced during the first days of the
prebiotic treatments (except during the first prebiotic treatment
with P95), which is typical for a fast fermentation and is prob-
ably due to a rapid increase in bifidobacteria. After a few days,
the lactate-utilising bacteria colonise the infant gut and lactate
decreased together with an increase in propionate. This was
likely due to the fermentation of lactate to propionate and acetate
at a ratio of 2:1, which can be done by many bacteria such as
Propionibacterium spp., Veillonella spp. or Clostridium spp.(47).
In conclusion, the present study showed that the in vitro
colonic model with immobilised infant microbiota can be
used to study several prebiotic substrates in the same trial
with the same microbiota. All three prebiotic substrates led
to significant increases in the bifidobacterial population and
in metabolite production. We conclude that the established
in vitro model is valid to test effects of fibre-type substrates
on the infant gut flora and could be a powerful model to
study diet modulation on the formula-fed infant microbiota.
Fig. 3. Changes in metabolite concentrations (mM) in faeces and fermentation medium for different times and fermentation periods. Acetate (W), propionate (O),
butyrate (D), lactate (X) and total SCFA (A) concentrations (mM) in the faecal inoculum and fermentation medium. Stab 1–4, stabilisation periods with the non-
prebiotic medium; P95, medium supplemented with oligofructose (Oraftiw P95); HSI, medium supplemented with inulin (Oraftiw HSI); Syn, medium supplemented
with oligofructose enriched-inulin (Oraftiw Synergy 1).
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